HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

terevalefim

Also Known As:

ANG-3777; SNV-003; refanalin

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - terevalefim: 3
  - Thiophenes: 257
    - terevalefim: 3
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiophenes: 257
    - terevalefim: 3

Experts

1.	Mayne, Tracy J: 3 articles (02/2021 - 12/2020)
2.	Gouveia, Deborah: 2 articles (02/2021 - 12/2020)
3.	Neylan, John F: 2 articles (02/2021 - 12/2020)
4.	Kim, Jim: 1 article (02/2021)
5.	Pelle, Gabrielle: 1 article (02/2021)
6.	Vincenti, Flavio: 1 article (02/2021)
7.	Bromberg, Jonathan S: 1 article (01/2021)
8.	Cal, Weizhong: 1 article (01/2021)
9.	Cooper, Matthew: 1 article (01/2021)
10.	Gaber, A Osama: 1 article (01/2021)

Related Diseases

1.	Delayed Graft Function 01/01/2021 - "Renal Function Improvement Following ANG-3777 Treatment in Patients at High Risk for Delayed Graft Function After Kidney Transplantation." 02/01/2021 - "Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function."
2.	Acute Kidney Injury (Acute Renal Failure) 12/01/2020 - "Hepatocyte Growth Factor Mimetic ANG-3777 for Cardiac Surgery-Associated Acute Kidney Injury."
3.	Reperfusion Injury 12/01/2020 - "In animal models, ANG-3777 mitigates the effects of renal damage secondary to ischemia reperfusion injury and nephrotoxic chemicals. "

Related Drugs and Biologics

1.	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)

Related Therapies and Procedures

1.	Kidney Transplantation